Arbutus Biopharma (ABUS) Directors and Executive Officers - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 
Arbutus Biopharma Corp  (NASDAQ: ABUS)

Arbutus Biopharma Corp

Officers & Directors


David C. Hastings
Chief Financial Officer
(Principal Financial Officer and Principal Accounting Officer)

Michael J. McElhaugh
Interim President and Chief Executive Officer
Director
(Principal Executive Officer)

Keith Manchester, M.D.
Director

Melissa V. Rewolinski, Ph.D.
Director

Frank Torti, M.D.
Director
(Chairman)

Richard C. Henriques
Director

James Meyers
Director

Daniel Burgess
Director ,

Arbutus Biopharma Corp currently has 19 employees.






ABUS Management Effectiveness ABUS Revenue per Employee ABUS Income per Employee


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.